Wilkins, Anna
Chauhan, Ritika
Rust, Alistair
Pearson, Alex
Daley, Frances
Manodoro, Floriana
Fenwick, Kerry
Bliss, Judith
Yarnold, John
Somaiah, Navita https://orcid.org/0000-0003-4609-0518
Funding for this research was provided by:
The Royal Marsden Hospital Charity (CP REF 09103)
Article History
Received: 5 January 2018
Accepted: 19 April 2018
First Online: 26 April 2018
Compliance with Ethical Standards
:
: The authors declare that they have no conflict of interest.
: Trans-Fraction was approved by The Royal Marsden Research Ethics Committee (08/H0801/53) on 23 July 2008. The START trial was approved by South East London Multicentre Research Ethics Committee (MREC 98/96) on 30 September 1998 and all patients provided informed consent including use of tissue and blood for research purposes.